original: Clinical trials with ALS patients showed that Riluzole lengthens survival by several months, and may have a greater survival benefit for those with a bulbar onset.
simplifications: Clinical trials with ALS patients showed that Riluzole lengthens survival by several months.  It may have a greater survival benefit for those with a bulbar onset. initial trials of Riluzole for ALS shows lengthened survival for several months with better benifits for people with a bulbar onset. Trials with ALS patients showed that Riluzole increases survival by several months, and may have a greater benefit for those with a bulbar onset. Riluzole lengthens survival by several months in ALS patients in clinical trials. It may have increased benefits in patients with bulbar onset. Clinical trials with ALS patients showed that Riluzole lengthens survival by several months. It may be more effective for those with a bulbar onset. Medical trials with ALS patients showed Riluzole increases survival by several months. It may help with survival more for people with a bulbar onset. Clinical trials showed that Riluzole allowed patients to live several months longer. Studies of ASL patients show that Riluzole can keep them alive several months longer . It may be more helpful for patients with a bulbar onset. Initial trials with ALS patients shows that Riluzole increased survival by months and may have a better benefit for those with bulbar onset. Clinical trials with ALS patients showed that Riluzole is very effective and may have a greater survival benefit for those with a bulbar onset.